Literature DB >> 19813196

Use of Evans blue dye to compare limb muscles in exercised young and old mdx mice.

Christine I Wooddell1, Guofeng Zhang, Jacob B Griffin, Julia O Hegge, Thierry Huss, Jon A Wolff.   

Abstract

Evans blue dye (EBD) is used to mark damaged and permeable muscle fibers in mouse models of muscular dystrophy and as an endpoint in therapeutic trials. We counted EBD-positive muscle fibers and extracted EBD from muscles sampled throughout the hindlimbs in young adult and old mdx mice to determine if the natural variability in morphology would allow measurement of a functional improvement in one limb compared to the contralateral limb. Following one bout of rotarod or treadmill exercise that greatly increased serum creatine kinase levels, the number of EBD(+) muscle fibers in 12-19-month-old mdx mice increased 3-fold, EBD in the muscles increased, and, importantly, contralateral pairs of muscles contained similar amounts of EBD. In contrast, the intra- and interlimb amounts of EBD in 2-7-month-old mdx mice were much too variable. A therapeutic effect can more readily be measured in old mdx mice. These results will be useful in the design of therapy protocols using the mdx mouse.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19813196     DOI: 10.1002/mus.21527

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  20 in total

1.  Muscle injury induced by different types of contractions in dystrophic mdx mice.

Authors:  Jianwei Lou; Wenbo Bi; Wei Li; Yuying Zhao; Shuping Liu; Jinfan Zheng; Chuanzhu Yan
Journal:  J Muscle Res Cell Motil       Date:  2012-02-11       Impact factor: 2.698

2.  Age-related T2 changes in hindlimb muscles of mdx mice.

Authors:  Ravneet S Vohra; Sunita Mathur; Nathan D Bryant; Sean C Forbes; Krista Vandenborne; Glenn A Walter
Journal:  Muscle Nerve       Date:  2015-07-14       Impact factor: 3.217

3.  Gender differences in contractile and passive properties of mdx extensor digitorum longus muscle.

Authors:  Chady H Hakim; Dongsheng Duan
Journal:  Muscle Nerve       Date:  2012-02       Impact factor: 3.217

4.  Sarcolemma instability during mechanical activity in Largemyd cardiac myocytes with loss of dystroglycan extracellular matrix receptor function.

Authors:  Zhyldyz Kabaeva; Kailyn E Meekhof; Daniel E Michele
Journal:  Hum Mol Genet       Date:  2011-05-30       Impact factor: 6.150

5.  Cardiac function in muscular dystrophy associates with abdominal muscle pathology.

Authors:  Brandon B Gardner; Kayleigh A Swaggart; Gene Kim; Sydeaka Watson; Elizabeth M McNally
Journal:  J Neuromuscul Dis       Date:  2015

6.  mdx(⁵cv) mice manifest more severe muscle dysfunction and diaphragm force deficits than do mdx Mice.

Authors:  Nicholas Beastrom; Haiyan Lu; Allison Macke; Benjamin D Canan; Eric K Johnson; Christopher M Penton; Brian K Kaspar; Louise R Rodino-Klapac; Lan Zhou; Paul M L Janssen; Federica Montanaro
Journal:  Am J Pathol       Date:  2011-09-03       Impact factor: 4.307

7.  Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion.

Authors:  Stephanie Duguez; William Duddy; Helen Johnston; Jeanne Lainé; Marie Catherine Le Bihan; Kristy J Brown; Anne Bigot; Yetrib Hathout; Gillian Butler-Browne; Terence Partridge
Journal:  Cell Mol Life Sci       Date:  2013-01-24       Impact factor: 9.261

8.  Acute failure of action potential conduction in mdx muscle reveals new mechanism of contraction-induced force loss.

Authors:  Jarrod A Call; Gordon L Warren; Mayank Verma; Dawn A Lowe
Journal:  J Physiol       Date:  2013-06-10       Impact factor: 5.182

9.  Endpoint measures in the mdx mouse relevant for muscular dystrophy pre-clinical studies.

Authors:  Yvonne M Kobayashi; Erik P Rader; Robert W Crawford; Kevin P Campbell
Journal:  Neuromuscul Disord       Date:  2011-12-10       Impact factor: 4.296

10.  Pregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoid.

Authors:  Yuko Shimizu-Motohashi; Yoko Asakura; Norio Motohashi; Nandkishore R Belur; Michael G Baumrucker; Atsushi Asakura
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.